Young Woong Lee

Title: Innovations of Young Woong Lee

Introduction

Young Woong Lee is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antimicrobial and anticancer agents. With a total of three patents to his name, his work has the potential to impact healthcare positively.

Latest Patents

One of his latest patents is focused on a multimeric antimicrobial peptide complex that is displayed on the cell surface. This invention provides an antimicrobial peptide polymer that comprises at least one monomer digested by pepsin. It includes a multimeric antimicrobial peptide complex linked to a cell surface anchoring motif. The invention allows for the administration of living microorganisms displaying the antimicrobial peptide without the need to lyse the microbial cell, significantly reducing production costs and enabling widespread use.

Another significant patent involves anticancer agents comprising peptides with cancer-specific toxicity. This invention relates to a prophylactic or therapeutic composition for cancer that includes a peptide represented by a specific amino acid sequence. The method for preventing or treating cancer involves administering this peptide to a subject, showcasing its potential in cancer therapy.

Career Highlights

Young Woong Lee has worked with prestigious institutions such as the Korea Advanced Institute of Science and Technology and the Intelligent Synthetic Biology Center. His research and innovations have contributed to advancements in biotechnology and medicine.

Collaborations

He has collaborated with notable colleagues, including Bong Hyun Sung and Sun-Chang Kim, who have also contributed to his research endeavors.

Conclusion

Young Woong Lee's innovative work in antimicrobial and anticancer agents highlights his significant role in advancing biotechnology. His patents reflect a commitment to improving healthcare solutions through scientific research and innovation.